Global nasal polyps treatment market is estimated to be valued at US$ 2,992.21 Mn in 2022 and is expected to exhibit a CAGR of 6.9% over the forecast period (2022-2030)
Figure 1: Global Nasal Polyps Treatment Market Share, (%), Analysis, By Drug Class, 2022
Market players are involved in launching of new products for the treatment of nasal polyps. This is expected to drive growth of the global nasal polyps treatment market over the forecast period.
Market players are developing new product and this is expected to drive growth of the global nasal polyps treatment market over the forecast period. For instance, in April 2018, Intersect ENT Inc. a subsidiary of Medtronic, a medical device company, launched a product, SINUVA. SINUVA is non-surgical option used for the treatment of nasal polyps. It reduced sinus obstacle and improves reduced sense of smell. It reduced symptoms of nasal obstacle and congestion for up to 90 days.
Figure 2: Global Nasal Polyps Treatment Market (US$ Bn), by Region, 2022
Nasal Polyps Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients